Premier Inc. is a leading healthcare improvement company, uniting an alliance of more than 4,100 U.S. hospitals and health systems and approximately 200,000 other providers and organizations to transform healthcare. With integrated data and analytics, collaboratives, supply chain solutions, and consulting and other services, Premier enables better care and outcomes at a lower cost. Premier plays a critical role in the rapidly evolving healthcare industry, collaborating with members to co-develop long-term innovations that reinvent and improve the way care is delivered to patients nationwide. Headquartered in Charlotte, N.C., Premier is passionate about transforming American healthcare.

Company profile
Ticker
PINC
Exchange
Website
CEO
Susan D. DeVore
Employees
Location
Fiscal year end
Sector
Industry (SIC)
Terminix Global • Mantech International • Gartner • R1 RCM • Franklin Covey • Jupai • Evolent Health • Veritec • Phi • Global Tech Industries ...
SEC CIK
Corporate docs
Subsidiaries
Premier Healthcare Solutions, Inc. • Premier Services II, LLC • Premier Healthcare Alliance, L.P. • Premier Supply Chain Improvement, Inc. • Premier Marketplace, LLC • Premier Supply Chain Holdings, LLC • NS3Health, LLC • SVS LLC • Commcare Pharmacy - FTL, LLC • Premier Specialty Pharmacy Solutions, LLC ...
PINC stock data
Analyst ratings and price targets
Current price
Average target
$34.00
Low target
$30.00
High target
$38.00
Credit Suisse
Upgraded
$38.00
JP Morgan
Maintains
$30.00
Latest filings (excl ownership)
8-K
Regulation FD Disclosure
10 Jan 23
8-K
Entry into a Material Definitive Agreement
16 Dec 22
8-K
Submission of Matters to a Vote of Security Holders
2 Dec 22
8-K
Premier, Inc. Reports Fiscal-Year 2023 First-Quarter Results
2 Nov 22
10-Q
2023 Q1
Quarterly report
1 Nov 22
8-K
Completes Asset Transaction for National Provider
19 Oct 22
DEF 14A
Definitive proxy
19 Oct 22
8-K
Regulation FD Disclosure
19 Oct 22
8-K
Premier, Inc.’s Subsidiary Contigo Health, LLC, to Acquire Contracts With 900,000 Providers and Licenses to Cost Containment Technology
7 Sep 22
S-8
Registration of securities for employees
22 Aug 22
Transcripts
PINC
Earnings call transcript
2023 Q1
1 Nov 22
PINC
Earnings call transcript
2022 Q4
16 Aug 22
PINC
Earnings call transcript
2022 Q3
3 May 22
PINC
Earnings call transcript
2022 Q2
1 Feb 22
PINC
Earnings call transcript
2022 Q1
2 Nov 21
PINC
Earnings call transcript
2021 Q4
17 Aug 21
PINC
Earnings call transcript
2021 Q3
4 May 21
PINC
Earnings call transcript
2021 Q2
2 Feb 21
PINC
Earnings call transcript
2021 Q1
3 Nov 20
PINC
Earnings call transcript
2020 Q4
25 Aug 20
Latest ownership filings
Financial summary
Quarter (USD) | Sep 22 | Jun 22 | Mar 22 | Dec 21 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Annual (USD) | Jun 22 | Jun 21 | Jun 20 | Jun 19 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
---|---|---|---|---|---|---|
Cash on hand (at last report) | 176.63 mm | 176.63 mm | 176.63 mm | 176.63 mm | 176.63 mm | 176.63 mm |
Cash burn (monthly) | (no burn) | 649.25 k | (no burn) | (no burn) | (no burn) | (no burn) |
Cash used (since last report) | n/a | 2.73 mm | n/a | n/a | n/a | n/a |
Cash remaining | n/a | 173.90 mm | n/a | n/a | n/a | n/a |
Runway (months of cash) | n/a | 267.8 | n/a | n/a | n/a | n/a |
Institutional ownership, Q3 2022
65.0% owned by funds/institutions
13F holders | Current |
---|---|
Total holders | 247 |
Opened positions | 28 |
Closed positions | 38 |
Increased positions | 94 |
Reduced positions | 99 |
13F shares | Current |
---|---|
Total value | 2.62 bn |
Total shares | 77.14 mm |
Total puts | 10.40 k |
Total calls | 36.60 k |
Total put/call ratio | 0.3 |
Largest owners | Shares | Value |
---|---|---|
Vanguard | 11.54 mm | $391.66 mm |
BLK Blackrock | 5.89 mm | $199.77 mm |
River Road Asset Management | 5.75 mm | $195.06 mm |
MKFCF Mackenzie Financial | 5.41 mm | $183.58 mm |
Dimensional Fund Advisors | 3.37 mm | $114.23 mm |
Burgundy Asset Management | 3.24 mm | $110.00 mm |
FMR | 2.80 mm | $95.19 mm |
First Trust Advisors | 2.58 mm | $87.59 mm |
Renaissance Technologies | 2.50 mm | $84.72 mm |
Adventist Health System Sunbelt Healthcare | 1.67 mm | $56.77 mm |
Recent insider trades
Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
6 Dec 22 | David L Klatsky | Class A Common Stock | Sale back to company | Dispose D | No | No | 0 | 5,502 | 0.00 | 81,723 |
5 Dec 22 | Bigalke John T. | Class A Common Stock | Grant | Acquire A | No | No | 0 | 4,636 | 0.00 | 17,649 |
5 Dec 22 | Boudreau Helen M | Class A Common Stock | Grant | Acquire A | No | No | 0 | 4,636 | 0.00 | 15,363 |
5 Dec 22 | Jody R Davids | Class A Common Stock | Grant | Acquire A | No | No | 0 | 4,636 | 0.00 | 20,199 |
5 Dec 22 | Peter Fine | Class A Common Stock | Grant | Acquire A | No | No | 0 | 4,636 | 0.00 | 28,016 |
News
Ritedose Awarded 503B Compounded Medications Agreement With Premier Effective January 1, 2023
30 Jan 23
Analyst Expectations for Premier's Future
27 Jan 23
Benzinga's Top Ratings Upgrades, Downgrades For January 27, 2023
27 Jan 23
Credit Suisse Upgrades Premier to Neutral, Announces $38 Price Target
27 Jan 23
Quest Diagnostics Awarded Laboratory Stewardship Platform And Services Agreement With Premier, Inc.
1 Dec 22
Press releases
Ritedose Awarded 503B Compounded Medications Agreement with Premier, Inc.
30 Jan 23
Premier, Inc. Declares Quarterly Cash Dividend
26 Jan 23
Premier, Inc. to Report Fiscal 2023 Second-Quarter Results and Host Conference Call on February 7, 2023
4 Jan 23
Premier Inc. to Participate in 41st Annual J.P. Morgan Healthcare Conference on January 10, 2023
3 Jan 23
Typenex® Medical Awarded Fluid Waste Management AscenDrive™/SURPASS Agreement with Premier, Inc.
15 Dec 22